Johann Willeit mainly focuses on Internal medicine, Risk factor, Diabetes mellitus, Prospective cohort study and Immunology. Johann Willeit combines subjects such as Endocrinology, Type 2 diabetes and Oncology with his study of Internal medicine. His Risk factor research incorporates themes from Surgery, Gerontology, Kidney disease and Environmental health.
The Environmental health study combines topics in areas such as Young adult, Obesity, Disease and Underweight. His studies deal with areas such as Body mass index, Epidemiology and Case-control study as well as Diabetes mellitus. Johann Willeit interconnects Odds ratio, Vascular disease and Endothelial progenitor cell in the investigation of issues within Immunology.
His primary scientific interests are in Internal medicine, Endocrinology, Prospective cohort study, Stroke and Disease. His Internal medicine study incorporates themes from Diabetes mellitus and Cardiology. Obesity, Global health and Gerontology is closely connected to Body mass index in his research, which is encompassed under the umbrella topic of Diabetes mellitus.
Johann Willeit usually deals with Endocrinology and limits it to topics linked to Risk factor and Relative risk. His research integrates issues of Incidence, Oncology and C-reactive protein in his study of Prospective cohort study. His work in Stroke tackles topics such as Surgery which are related to areas like Cohort.
His main research concerns Internal medicine, Disease, Cohort, Endocrinology and Epidemiology. In his study, Stroke and Blood pressure is strongly linked to Cardiology, which falls under the umbrella field of Internal medicine. The study incorporates disciplines such as Relative risk, Physical therapy and Pediatrics in addition to Disease.
As part of one scientific family, Johann Willeit deals mainly with the area of Cohort, narrowing it down to issues related to the Cohort study, and often Proportional hazards model. His work focuses on many connections between Confidence interval and other disciplines, such as Risk factor, that overlap with his field of interest in Framingham Risk Score, Pooled analysis and Global health. His studies link Body mass index with Diabetes mellitus.
Johann Willeit mainly investigates Internal medicine, Body mass index, Prospective cohort study, Epidemiology and Global health. His Internal medicine research integrates issues from Diabetes mellitus, Endocrinology and Type 2 diabetes. In his study, Young adult is inextricably linked to Obesity, which falls within the broad field of Body mass index.
He works mostly in the field of Prospective cohort study, limiting it down to topics relating to Meta-analysis and, in certain cases, Framingham Risk Score, as a part of the same area of interest. His work carried out in the field of Epidemiology brings together such families of science as Vulnerable plaque, Proteomics, Biomarker discovery and Disease. His Global health study combines topics in areas such as Pooled analysis, Gerontology, Environmental health, Blood pressure and Risk factor.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults
Leandra Abarca-Gómez;Ziad A Abdeen;Zargar Abdul Hamid;Niveen M Abu-Rmeileh.
Trends in adult body-mass index in 200 countries from 1975 to 2014: A pooled analysis of 1698 population-based measurement studies with 19.2 million participants
Mariachiara Di Cesare;Mariachiara Di Cesare;James Bentham;Gretchen A Stevens;Bin Zhou.
Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants
Bin Zhou;Yuan Lu;Kaveh Hajifathalian;James Bentham.
The Lancet (2016)
Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants
Bin Zhou;James Bentham;Mariachiara Di Cesare;Honor Bixby.
The Lancet (2017)
Plasma MicroRNA Profiling Reveals Loss of Endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes
Anna Zampetaki;Stefan Kiechl;Ignat Drozdov;Peter Willeit.
Circulation Research (2010)
Toll-like Receptor 4 Polymorphisms and Atherogenesis
Stefan Kiechl;Eva Lorenz;Markus Reindl;Christian J Wiedermann.
The New England Journal of Medicine (2002)
A century of trends in adult human height
James Bentham;Mariachiara Di Cesare;Mariachiara Di Cesare;Gretchen A. Stevens;Bin Zhou.
Chronic Infections and the Risk of Carotid Atherosclerosis Prospective Results From a Large Population Study
Stefan Kiechl;Georg Egger;Manuel Mayr;Christian J. Wiedermann.
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular Disease
Stefan Kiechl;Georg Schett;Gregor Wenning;Kurt Redlich.
Cardioprotection and lifespan extension by the natural polyamine spermidine
Tobias Eisenberg;Mahmoud Abdellatif;Sabrina Schroeder;Uwe Primessnig;Uwe Primessnig.
Nature Medicine (2016)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: